Cell Therapeutics takes no chances

Most companies only bite the bullet and downsize when disaster is imminent. But after raising $32 million from private investors, Cell Therapeutics Inc. is proactively restructuring as it prepares to go into pivotal clinical trials.

The company

Read the full 368 word article

How to gain access

Continue reading with a
two-week free trial.